Authors: MIKHAIL G EADON H LEAVER N KHAGHANI A YACOUB M BANNER N

Citation: G. Mikhail et al., COMPARISON OF NEORAL AND SANDIMMUN CYCLOSPORINES FOR DE-NOVO LUNG TRANSPLANTATION IN CYSTIC-FIBROSIS PATIENTS, Transplantation proceedings, 30(4), 1998, pp. 1510-1511

Authors: MIKHAIL G EADON H LEAVER N ROGERS P STEPHENS D BANNER N KHAGHANI A YACOUB M

Citation: G. Mikhail et al., AN INVESTIGATION OF THE PHARMACOKINETICS, TOXICITY, AND CLINICAL EFFICACY OF NEORAL CYCLOSPORINE IN CYSTIC-FIBROSIS PATIENTS, Transplantation proceedings, 29(1-2), 1997, pp. 599-601

Authors: EADON H ROSE M ONEILL R LEAVER N YACOUB M

Citation: H. Eadon et al., A PHARMACOKINETIC COMPARISON OF CYCLOSPORINE ORAL SOLUTION AND CYCLOSPORINE CAPSULES IN HEART AND LUNG-TRANSPLANT RECIPIENTS, Transplant international, 8(1), 1995, pp. 35-40

Authors: MIKHAIL GW EADON H ROGERS P LEAVER N BANNER NR KHAGHANI A YACOUB MH

Citation: Gw. Mikhail et al., MICROEMULSION FORMULATION INCREASES CYCLOSPORINE BIOAVAILABILITY IN CYSTIC-FIBROSIS, Lancet, 346(8990), 1995, pp. 1638-1639

Authors: MIKHAIL G EADON H LEAVER N YACOUB M

Citation: G. Mikhail et al., USE OF NEORAL IN HEART-TRANSPLANT RECIPIENTS, Transplantation proceedings, 26(5), 1994, pp. 2985-2987